Health · 2 views
mRNA Melanoma Vaccine Cuts Risk of Recurrence or Death, Leaked Trial Data Show
(MedPage Today) -- Adjuvant treatment with the mRNA-based cancer vaccine intismeran autogene plus pembrolizumab (Keytruda) significantly improved recurrence-free survival (RFS) in patients with resected stage IIB-IV melanoma, the phase…
Summary
(MedPage Today) -- Adjuvant treatment with the mRNA-based cancer vaccine intismeran autogene plus pembrolizumab (Keytruda) significantly improved recurrence-free survival (RFS) in patients with resected stage IIB-IV melanoma, the phase III INTerpath
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- ESMO: New analysis reinforces survival benefits of targeted therapy for advanced pancreatic cancerContinue reading
- Scientists propose national microbiome plan to prevent chronic diseaseContinue reading
- I'm a Forensic Psychiatrist. Here's My Take on the Elizabeth Holmes Documentary.Continue reading
- Study finds patients experienced rapid weight gain after starting antipsychotic medicationContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow